$中国抗体-B(03_老虎社区_美港股上老虎

$中国抗体-B(03681)$ 智通财经APP讯，中国抗体-B(03681)公布，李之秀女士及申楠先生已获委任为独立非执行董事及公司审核委员会及提名委员会各自的成员，自2025年6月30日起生效。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":452248567173520,"tweetId":"452248567173520","gmtCreate":1751379402849,"gmtModify":1751379404186,"author":{"id":4108559598165560,"idStr":"4108559598165560","authorId":4108559598165560,"authorIdStr":"4108559598165560","name":"稍微放量","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":30,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/03681\">$中国抗体-B(03681)$ </a> 智通财经APP讯，中国抗体-B(03681)公布，李之秀女士及申楠先生已获委任为独立非执行董事及公司审核委员会及提名委员会各自的成员，自2025年6月30日起生效。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/03681\">$中国抗体-B(03681)$ </a> 智通财经APP讯，中国抗体-B(03681)公布，李之秀女士及申楠先生已获委任为独立非执行董事及公司审核委员会及提名委员会各自的成员，自2025年6月30日起生效。</p></body></html>","text":"$中国抗体-B(03681)$ 智通财经APP讯，中国抗体-B(03681)公布，李之秀女士及申楠先生已获委任为独立非执行董事及公司审核委员会及提名委员会各自的成员，自2025年6月30日起生效。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/452248567173520","repostId":0,"isVote":1,"tweetType":1,"viewCount":409,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["03681"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":160,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/452248567173520"}